Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone H3K27 trimethyltransferase activity	EZH1 EZH2	7.46e-06	3	32	2	GO:0140951
GeneOntologyMolecularFunction	histone H3K27 methyltransferase activity	EZH1 EZH2	3.72e-05	6	32	2	GO:0046976
GeneOntologyMolecularFunction	transmembrane-ephrin receptor activity	EPHB2 EPHA8	2.58e-04	15	32	2	GO:0005005
GeneOntologyMolecularFunction	protein kinase activity	EPHB2 TRIO KALRN MMD2 CHUK EPHA8	3.34e-04	600	32	6	GO:0004672
GeneOntologyMolecularFunction	ephrin receptor activity	EPHB2 EPHA8	4.18e-04	19	32	2	GO:0005003
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	EPHB2 TRIO KALRN MMD2 CHUK EPHA8	8.07e-04	709	32	6	GO:0016773
GeneOntologyMolecularFunction	kinase activity	EPHB2 TRIO KALRN MMD2 CHUK EPHA8	1.19e-03	764	32	6	GO:0016301
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	EZH1 EZH2	2.26e-03	44	32	2	GO:0140938
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	EPHB2 TRIO KALRN MMD2 CHUK EPHA8	3.36e-03	938	32	6	GO:0016772
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	EPHB2 EPHA8	4.86e-03	65	32	2	GO:0004714
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	EZH1 EZH2	5.31e-03	68	32	2	GO:0016279
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	EZH1 EZH2	5.46e-03	69	32	2	GO:0016278
GeneOntologyMolecularFunction	histone methyltransferase activity	EZH1 EZH2	5.77e-03	71	32	2	GO:0042054
GeneOntologyMolecularFunction	histone modifying activity	EYA2 EZH1 EZH2	5.78e-03	229	32	3	GO:0140993
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	PLEKHG1 TRIO KALRN	5.92e-03	231	32	3	GO:0005085
GeneOntologyBiologicalProcess	hepatocyte homeostasis	EZH1 EZH2	2.48e-06	2	33	2	GO:0036333
GeneOntologyBiologicalProcess	regulation of small GTPase mediated signal transduction	EPHB2 PLEKHG1 TRIM67 TRIO KALRN MMD2	1.30e-05	333	33	6	GO:0051056
GeneOntologyBiologicalProcess	small GTPase-mediated signal transduction	EPHB2 PLEKHG1 TRIM67 TRIO KALRN MMD2 CHUK	1.87e-05	538	33	7	GO:0007264
GeneOntologyBiologicalProcess	response to tetrachloromethane	EZH1 EZH2	2.47e-05	5	33	2	GO:1904772
GeneOntologyBiologicalProcess	ephrin receptor signaling pathway	EPHB2 KALRN EPHA8	8.75e-05	54	33	3	GO:0048013
GeneOntologyBiologicalProcess	subtelomeric heterochromatin formation	EZH1 EZH2	8.87e-05	9	33	2	GO:0031509
GeneOntologyBiologicalProcess	regulation of Ras protein signal transduction	EPHB2 TRIM67 MMD2	1.26e-04	61	33	3	GO:0046578
GeneOntologyBiologicalProcess	neuron projection development	EPHB2 SPTBN4 DIP2B TRIM67 EZH2 TRIO KALRN TPBG EPHA8	1.36e-04	1285	33	9	GO:0031175
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	EPHB2 SPTBN4 DIP2B TRIO KALRN TPBG EPHA8	1.50e-04	748	33	7	GO:0048667
GeneOntologyBiologicalProcess	constitutive heterochromatin formation	EZH1 EZH2	1.91e-04	13	33	2	GO:0140719
GeneOntologyBiologicalProcess	neuron projection morphogenesis	EPHB2 SPTBN4 DIP2B TRIO KALRN TPBG EPHA8	2.31e-04	802	33	7	GO:0048812
GeneOntologyBiologicalProcess	axonogenesis	EPHB2 SPTBN4 DIP2B TRIO KALRN EPHA8	2.45e-04	566	33	6	GO:0007409
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	EPHB2 SPTBN4 DIP2B TRIO KALRN TPBG EPHA8	2.62e-04	819	33	7	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	EPHB2 SPTBN4 DIP2B TRIO KALRN TPBG EPHA8	2.76e-04	826	33	7	GO:0048858
GeneOntologyBiologicalProcess	neuron development	EPHB2 SPTBN4 DIP2B TRIM67 EZH2 TRIO KALRN TPBG EPHA8	3.60e-04	1463	33	9	GO:0048666
GeneOntologyBiologicalProcess	axon development	EPHB2 SPTBN4 DIP2B TRIO KALRN EPHA8	4.80e-04	642	33	6	GO:0061564
GeneOntologyBiologicalProcess	positive regulation of neuron projection development	EPHB2 TRIM67 EZH2 KALRN	6.44e-04	249	33	4	GO:0010976
GeneOntologyCellularComponent	ESC/E(Z) complex	EZH1 EZH2	3.24e-04	17	33	2	GO:0035098
Domain	EZH2_WD-Binding	EZH1 EZH2	3.03e-06	2	33	2	PF11616
Domain	CXC_dom	EZH1 EZH2	3.03e-06	2	33	2	IPR026489
Domain	CXC	EZH1 EZH2	3.03e-06	2	33	2	PS51633
Domain	EZH1/EZH2	EZH1 EZH2	3.03e-06	2	33	2	IPR021654
Domain	Spectrin	SPTBN4 TRIO KALRN	8.69e-06	23	33	3	PF00435
Domain	Spectrin_repeat	SPTBN4 TRIO KALRN	1.78e-05	29	33	3	IPR002017
Domain	Spectrin/alpha-actinin	SPTBN4 TRIO KALRN	2.41e-05	32	33	3	IPR018159
Domain	SPEC	SPTBN4 TRIO KALRN	2.41e-05	32	33	3	SM00150
Domain	DMAP_binding	DIP2C DIP2B	3.02e-05	5	33	2	PF06464
Domain	Tesmin/TSO1-like_CXC	EZH1 EZH2	4.52e-05	6	33	2	IPR033467
Domain	DMAP_binding	DIP2C DIP2B	4.52e-05	6	33	2	SM01137
Domain	CXC	EZH1 EZH2	4.52e-05	6	33	2	SM01114
Domain	DMAP1-bd	DIP2C DIP2B	4.52e-05	6	33	2	IPR010506
Domain	fn3	EPHB2 TRIM67 KALRN EPHA8	1.83e-04	162	33	4	PF00041
Domain	DH_1	PLEKHG1 TRIO KALRN	1.86e-04	63	33	3	PS00741
Domain	RhoGEF	PLEKHG1 TRIO KALRN	2.33e-04	68	33	3	SM00325
Domain	DH_2	PLEKHG1 TRIO KALRN	2.54e-04	70	33	3	PS50010
Domain	RhoGEF	PLEKHG1 TRIO KALRN	2.54e-04	70	33	3	PF00621
Domain	DH-domain	PLEKHG1 TRIO KALRN	2.65e-04	71	33	3	IPR000219
Domain	-	PLEKHG1 TRIO KALRN	2.65e-04	71	33	3	1.20.900.10
Domain	RECEPTOR_TYR_KIN_V_2	EPHB2 EPHA8	2.72e-04	14	33	2	PS00791
Domain	RECEPTOR_TYR_KIN_V_1	EPHB2 EPHA8	2.72e-04	14	33	2	PS00790
Domain	EphA2_TM	EPHB2 EPHA8	2.72e-04	14	33	2	PF14575
Domain	Tyr_kinase_ephrin_rcpt	EPHB2 EPHA8	2.72e-04	14	33	2	IPR016257
Domain	Eph_TM	EPHB2 EPHA8	2.72e-04	14	33	2	IPR027936
Domain	Ephrin_rcpt_lig-bd_dom	EPHB2 EPHA8	2.72e-04	14	33	2	IPR001090
Domain	Tyr_kinase_rcpt_V_CS	EPHB2 EPHA8	2.72e-04	14	33	2	IPR001426
Domain	EPH_LBD	EPHB2 EPHA8	2.72e-04	14	33	2	PS51550
Domain	EPH_lbd	EPHB2 EPHA8	2.72e-04	14	33	2	SM00615
Domain	Ephrin_lbd	EPHB2 EPHA8	2.72e-04	14	33	2	PF01404
Domain	FN3	EPHB2 TRIM67 KALRN EPHA8	3.05e-04	185	33	4	SM00060
Domain	FN3	EPHB2 TRIM67 KALRN EPHA8	4.02e-04	199	33	4	PS50853
Domain	FN3_dom	EPHB2 TRIM67 KALRN EPHA8	4.83e-04	209	33	4	IPR003961
Domain	SAM	EPHB2 WDSUB1 EPHA8	4.98e-04	88	33	3	SM00454
Domain	CRAL_TRIO	TRIO KALRN	6.23e-04	21	33	2	PF00650
Domain	SAM_DOMAIN	EPHB2 WDSUB1 EPHA8	6.23e-04	95	33	3	PS50105
Domain	SAM	EPHB2 WDSUB1 EPHA8	6.62e-04	97	33	3	IPR001660
Domain	PH	SPTBN4 PLEKHG1 TRIO KALRN	6.81e-04	229	33	4	PF00169
Domain	-	TRIO KALRN	7.48e-04	23	33	2	3.40.525.10
Domain	-	EPHB2 WDSUB1 EPHA8	8.57e-04	106	33	3	1.10.150.50
Domain	Ephrin_rec_like	EPHB2 EPHA8	8.85e-04	25	33	2	SM01411
Domain	SEC14	TRIO KALRN	8.85e-04	25	33	2	SM00516
Domain	Tyr-kin_ephrin_A/B_rcpt-like	EPHB2 EPHA8	8.85e-04	25	33	2	IPR011641
Domain	CRAL_TRIO	TRIO KALRN	1.03e-03	27	33	2	PS50191
Domain	CRAL-TRIO_dom	TRIO KALRN	1.11e-03	28	33	2	IPR001251
Domain	SAM/pointed	EPHB2 WDSUB1 EPHA8	1.14e-03	117	33	3	IPR013761
Domain	PROTEIN_KINASE_ATP	EPHB2 TRIO KALRN CHUK EPHA8	1.18e-03	459	33	5	PS00107
Domain	AMP-binding	DIP2C DIP2B	1.28e-03	30	33	2	PF00501
Domain	AMP-dep_Synth/Lig	DIP2C DIP2B	1.28e-03	30	33	2	IPR000873
Domain	PH	SPTBN4 PLEKHG1 TRIO KALRN	1.40e-03	278	33	4	SM00233
Domain	PH_DOMAIN	SPTBN4 PLEKHG1 TRIO KALRN	1.42e-03	279	33	4	PS50003
Domain	PH_domain	SPTBN4 PLEKHG1 TRIO KALRN	1.44e-03	280	33	4	IPR001849
Domain	Prot_kinase_dom	EPHB2 TRIO KALRN CHUK EPHA8	1.56e-03	489	33	5	IPR000719
Domain	PROTEIN_KINASE_DOM	EPHB2 TRIO KALRN CHUK EPHA8	1.62e-03	493	33	5	PS50011
Domain	GDS_CDC24_CS	PLEKHG1 TRIO	2.15e-03	39	33	2	IPR001331
Domain	SET	EZH1 EZH2	2.38e-03	41	33	2	PF00856
Domain	Kinase-like_dom	EPHB2 TRIO KALRN CHUK EPHA8	2.45e-03	542	33	5	IPR011009
Domain	SET	EZH1 EZH2	2.98e-03	46	33	2	SM00317
Domain	SET_dom	EZH1 EZH2	3.52e-03	50	33	2	IPR001214
Domain	SANT	EZH1 EZH2	3.52e-03	50	33	2	SM00717
Domain	SET	EZH1 EZH2	3.52e-03	50	33	2	PS50280
Domain	SANT/Myb	EZH1 EZH2	3.80e-03	52	33	2	IPR001005
Domain	Protein_kinase_ATP_BS	EPHB2 KALRN CHUK EPHA8	4.29e-03	379	33	4	IPR017441
Domain	-	SPTBN4 PLEKHG1 TRIO KALRN	4.79e-03	391	33	4	2.30.29.30
Pathway	REACTOME_NERVOUS_SYSTEM_DEVELOPMENT	EPHB2 SPTBN4 TRIO KALRN EPHA8	5.36e-05	261	23	5	MM15676
Pathway	WP_NODLIKE_RECEPTOR_NLR_SIGNALING	EPHB2 CHUK	9.10e-05	9	23	2	M39494
Pathway	WP_NODLIKE_RECEPTOR_NLR_SIGNALING_PATHWAY	EPHB2 CHUK	9.10e-05	9	23	2	MM15889
Pathway	BIOCARTA_PRC2_PATHWAY	EZH1 EZH2	1.39e-04	11	23	2	MM1548
Pathway	REACTOME_EPH_EPHRIN_SIGNALING	EPHB2 KALRN EPHA8	1.55e-04	65	23	3	MM14911
Pathway	BIOCARTA_PRC2_PATHWAY	EZH1 EZH2	2.29e-04	14	23	2	M22025
Pathway	WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2	EZH1 EZH2	3.01e-04	16	23	2	M39484
Pathway	REACTOME_EPH_EPHRIN_SIGNALING	EPHB2 KALRN EPHA8	4.33e-04	92	23	3	M27201
Pathway	KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119	EZH1 EZH2	5.77e-04	22	23	2	M47924
Pathway	REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER	RICTOR CHUK	8.08e-04	26	23	2	M27558
Pathway	KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES	EZH1 EZH2	8.72e-04	27	23	2	M47941
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	EPHB2 SPTBN4 TRIO KALRN EPHA8	1.11e-03	502	23	5	MM14537
Pathway	REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS	EPHB2 EPHA8	1.38e-03	34	23	2	MM15025
Pathway	PID_PI3KCI_AKT_PATHWAY	RICTOR CHUK	1.47e-03	35	23	2	M249
Pathway	REACTOME_DEATH_RECEPTOR_SIGNALING	TRIO KALRN CHUK	1.53e-03	142	23	3	MM15431
Pathway	REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING	EPHB2 KALRN	1.64e-03	37	23	2	MM15022
Pathway	PID_RAC1_REG_PATHWAY	TRIO KALRN	1.73e-03	38	23	2	M241
Pathway	REACTOME_SYNTHESIS_OF_PA	PLA2R1 AGPAT5	1.82e-03	39	23	2	M653
Pathway	WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT	EPHB2 TRIO	1.91e-03	40	23	2	M39798
Pathway	PID_EPHB_FWD_PATHWAY	EPHB2 KALRN	1.91e-03	40	23	2	M62
Pathway	KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119	EZH1 EZH2	1.91e-03	40	23	2	M47917
Pathway	REACTOME_DEATH_RECEPTOR_SIGNALING	TRIO KALRN CHUK	1.93e-03	154	23	3	M27697
Pathway	REACTOME_SYNTHESIS_OF_PA	PLA2R1 AGPAT5	2.01e-03	41	23	2	MM14583
Pathway	REACTOME_NERVOUS_SYSTEM_DEVELOPMENT	EPHB2 SPTBN4 TRIO KALRN EPHA8	2.03e-03	575	23	5	M29853
Pathway	REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING	EPHB2 KALRN	2.11e-03	42	23	2	M27308
Pathway	WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER	EPHB2 TRIO	2.21e-03	43	23	2	M39788
Pubmed	The competitive mechanism of EZH1 and EZH2 in promoting oral squamous cell carcinoma.	EZH1 EZH2	9.28e-07	2	34	2	38309675
Pubmed	Sex-biased genetic programs in liver metabolism and liver fibrosis are controlled by EZH1 and EZH2.	EZH1 EZH2	9.28e-07	2	34	2	32428001
Pubmed	Mammalian homologues of the Polycomb-group gene Enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S. cerevisiae telomeres.	EZH1 EZH2	9.28e-07	2	34	2	9214638
Pubmed	PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs.	EZH1 EZH2	9.28e-07	2	34	2	28939884
Pubmed	EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair.	EZH1 EZH2	9.28e-07	2	34	2	21317239
Pubmed	Aberrant differential expression of EZH1 and EZH2 in Polycomb repressive complex 2 among B- and T/NK-cell neoplasms.	EZH1 EZH2	9.28e-07	2	34	2	27311868
Pubmed	Characterization of EZH1, a human homolog of Drosophila Enhancer of zeste near BRCA1.	EZH1 EZH2	9.28e-07	2	34	2	8921387
Pubmed	Developmental control of polycomb subunit composition by GATA factors mediates a switch to non-canonical functions.	EZH1 EZH2	9.28e-07	2	34	2	25578878
Pubmed	The methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regeneration.	EZH1 EZH2	9.28e-07	2	34	2	25477280
Pubmed	EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation.	EZH1 EZH2	9.28e-07	2	34	2	30522506
Pubmed	The role of EZH1 and EZH2 in development and cancer.	EZH1 EZH2	9.28e-07	2	34	2	36476271
Pubmed	Cloning and expression of a human/mouse Polycomb group gene, ENX-2/Enx-2.	EZH1 EZH2	9.28e-07	2	34	2	9473645
Pubmed	Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas.	EZH1 EZH2	9.28e-07	2	34	2	31747604
Pubmed	Polycomb repressive complex 2 (PRC2) silences genes responsible for neurodegeneration.	EZH1 EZH2	9.28e-07	2	34	2	27526204
Pubmed	The murine polycomb-group genes Ezh1 and Ezh2 map close to Hox gene clusters on mouse chromosomes 11 and 6.	EZH1 EZH2	9.28e-07	2	34	2	10051331
Pubmed	EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer.	EZH1 EZH2	9.28e-07	2	34	2	30867289
Pubmed	Rapid induction of dendritic spine morphogenesis by trans-synaptic ephrinB-EphB receptor activation of the Rho-GEF kalirin.	EPHB2 KALRN	9.28e-07	2	34	2	12546821
Pubmed	EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy.	EZH1 EZH2	9.28e-07	2	34	2	27897169
Pubmed	Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP.	TRIO KALRN	9.28e-07	2	34	2	26858404
Pubmed	Polycomb Repressive Complex 2 Proteins EZH1 and EZH2 Regulate Timing of Postnatal Hepatocyte Maturation and Fibrosis by Repressing Genes With Euchromatic Promoters in Mice.	EZH1 EZH2	9.28e-07	2	34	2	30689973
Pubmed	CGG-repeat expansion in the DIP2B gene is associated with the fragile site FRA12A on chromosome 12q13.1.	DIP2C DIP2B	2.78e-06	3	34	2	17236128
Pubmed	Signaling function of PRC2 is essential for TCR-driven T cell responses.	EZH1 EZH2	2.78e-06	3	34	2	29523590
Pubmed	Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts.	EZH1 EZH2	2.78e-06	3	34	2	27823969
Pubmed	Ezh1 Targets Bivalent Genes to Maintain Self-Renewing Stem Cells in Ezh2-Insufficient Myelodysplastic Syndrome.	EZH1 EZH2	2.78e-06	3	34	2	30396150
Pubmed	Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner.	EZH1 EZH2	2.78e-06	3	34	2	26219303
Pubmed	The polycomb-group gene Ezh2 is required for early mouse development.	EZH1 EZH2	2.78e-06	3	34	2	11390661
Pubmed	Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2.	EZH1 EZH2	2.78e-06	3	34	2	27630126
Pubmed	Genetic analysis of the role of Eph receptors in the development of the mammalian nervous system.	EPHB2 EPHA8	2.78e-06	3	34	2	9321682
Pubmed	Synaptic Kalirin-7 and Trio Interactomes Reveal a GEF Protein-Dependent Neuroligin-1 Mechanism of Action.	TRIO KALRN	2.78e-06	3	34	2	31801062
Pubmed	eek and erk, new members of the eph subclass of receptor protein-tyrosine kinases.	EPHB2 EPHA8	2.78e-06	3	34	2	1648701
Pubmed	Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells.	EZH1 EZH2	2.78e-06	3	34	2	22042701
Pubmed	Polycomb subunits Ezh1 and Ezh2 regulate the Merkel cell differentiation program in skin stem cells.	EZH1 EZH2	2.78e-06	3	34	2	23673358
Pubmed	Ezh1 and Ezh2 differentially regulate PSD-95 gene transcription in developing hippocampal neurons.	EZH1 EZH2	5.56e-06	4	34	2	23932971
Pubmed	Polycomb Ezh1 maintains murine muscle stem cell quiescence through non-canonical regulation of Notch signaling.	EZH1 EZH2	5.56e-06	4	34	2	37105173
Pubmed	EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency.	EZH1 EZH2	5.56e-06	4	34	2	19026780
Pubmed	Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms.	EZH1 EZH2	5.56e-06	4	34	2	19026781
Pubmed	Regulation of embryonic haematopoietic multipotency by EZH1.	EZH1 EZH2	5.56e-06	4	34	2	29342143
Pubmed	Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation.	EZH1 EZH2	5.56e-06	4	34	2	31189531
Pubmed	New quantitative trait loci that regulate wound healing in an intercross progeny from DBA/1J and 129 x 1/SvJ inbred strains of mice.	EPHB2 EPHA8	9.26e-06	5	34	2	16208538
Pubmed	A covalently bound inhibitor triggers EZH2 degradation through CHIP-mediated ubiquitination.	EZH1 EZH2	9.26e-06	5	34	2	28320739
Pubmed	Assembly of high order G alpha q-effector complexes with RGS proteins.	TRIO KALRN	9.26e-06	5	34	2	18936096
Pubmed	PRC2 insufficiency causes p53-dependent dyserythropoiesis in myelodysplastic syndrome.	EZH1 EZH2	9.26e-06	5	34	2	32820269
Pubmed	Interaction of mouse polycomb-group (Pc-G) proteins Enx1 and Enx2 with Eed: indication for separate Pc-G complexes.	EZH1 EZH2	9.26e-06	5	34	2	9584197
Pubmed	IKK interacts with rictor and regulates mTORC2.	RICTOR CHUK	1.39e-05	6	34	2	23872070
Pubmed	X chromosome reactivation and regulation in cloned embryos.	EZH1 EZH2	1.94e-05	7	34	2	15733677
Pubmed	Loss of Ezh2 in the medial ganglionic eminence alters interneuron fate, cell morphology and gene expression profiles.	EZH1 EZH2	2.59e-05	8	34	2	38419656
Pubmed	Polycomb-like 2 associates with PRC2 and regulates transcriptional networks during mouse embryonic stem cell self-renewal and differentiation.	EZH1 EZH2	2.59e-05	8	34	2	20144788
Pubmed	New insights into BS69 functions.	EZH1 EZH2	2.59e-05	8	34	2	16565076
Pubmed	PRC2 directly methylates GATA4 and represses its transcriptional activity.	EZH1 EZH2	3.33e-05	9	34	2	22215809
Pubmed	EZH1 in germ cells safeguards the function of PRC2 during spermatogenesis.	EZH1 EZH2	3.33e-05	9	34	2	28254491
Pubmed	Ezh2-dependent methylation in oral epithelia promotes secondary palatogenesis.	EZH1 EZH2	3.33e-05	9	34	2	37435868
Pubmed	JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells.	EZH1 EZH2	3.33e-05	9	34	2	20075857
Pubmed	HUWE1 E3 ligase promotes PINK1/PARKIN-independent mitophagy by regulating AMBRA1 activation via IKKα.	GABARAPL2 CHUK	4.15e-05	10	34	2	30217973
Pubmed	Divergent Requirements for EZH1 in Heart Development Versus Regeneration.	EZH1 EZH2	4.15e-05	10	34	2	28512107
Pubmed	EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells.	EZH1 EZH2	4.15e-05	10	34	2	31451685
Pubmed	Polycomb-like 3 promotes polycomb repressive complex 2 binding to CpG islands and embryonic stem cell self-renewal.	EZH1 EZH2	5.07e-05	11	34	2	22438827
Pubmed	Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin.	SPTBN4 KALRN	5.07e-05	11	34	2	17607528
Pubmed	An H3K36 methylation-engaging Tudor motif of polycomb-like proteins mediates PRC2 complex targeting.	EZH1 EZH2	5.07e-05	11	34	2	23273982
Pubmed	Conditional ablation of Ezh2 in murine hearts reveals its essential roles in endocardial cushion formation, cardiomyocyte proliferation and survival.	EZH1 EZH2	6.08e-05	12	34	2	22312437
Pubmed	Maternal Ezh1/2 deficiency in oocyte delays H3K27me2/3 restoration and impairs epiblast development responsible for embryonic sub-lethality in mouse.	EZH1 EZH2	7.19e-05	13	34	2	35796552
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	DIP2B RICTOR EZH2 INTS3 KLHDC4 CLASRP	9.41e-05	774	34	6	15302935
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	SPTBN4 DIP2B TRIO KALRN	1.04e-04	251	34	4	27507650
Pubmed	Dissecting the Roles of Polycomb Repressive Complex 2 Subunits in the Control of Skin Development.	EZH1 EZH2	1.10e-04	16	34	2	26994968
Pubmed	PRC2 Acts as a Critical Timer That Drives Oligodendrocyte Fate over Astrocyte Identity by Repressing the Notch Pathway.	EZH1 EZH2	1.10e-04	16	34	2	32937136
Pubmed	KDM6B interacts with TFDP1 to activate P53 signaling in regulating mouse palatogenesis.	EZH1 EZH2	1.10e-04	16	34	2	35212626
Pubmed	Rnf2 (Ring1b) deficiency causes gastrulation arrest and cell cycle inhibition.	EZH1 EZH2	1.25e-04	17	34	2	12589020
Pubmed	Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice.	EPHB2 EPHA8	1.25e-04	17	34	2	12217323
Pubmed	Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells.	EZH1 EZH2	1.41e-04	18	34	2	19303854
Pubmed	Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells.	EZH1 EZH2	1.41e-04	18	34	2	20064376
Pubmed	Polycomb repressive complex 2 regulates normal development of the mouse heart.	EZH1 EZH2	1.57e-04	19	34	2	22158708
Pubmed	The polycomb proteins EZH1 and EZH2 co-regulate chromatin accessibility and nephron progenitor cell lifespan in mice.	EZH1 EZH2	1.57e-04	19	34	2	32554463
Pubmed	Protein Palmitoylation by ZDHHC13 Protects Skin against Microbial-Driven Dermatitis.	EPHB2 CHUK	1.57e-04	19	34	2	28017833
Pubmed	Postnatal onset of retinal degeneration by loss of embryonic Ezh2 repression of Six1.	EYA2 EZH2	1.57e-04	19	34	2	27677711
Pubmed	Expression of Ephs and ephrins in developing mouse inner ear.	EPHB2 EPHA8	1.57e-04	19	34	2	12684176
Pubmed	Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis.	EZH1 EZH2	1.74e-04	20	34	2	22267199
Pubmed	Eph receptors and ephrins: effectors of morphogenesis.	EPHB2 EPHA8	1.74e-04	20	34	2	10207129
Pubmed	Multiple roles of EPH receptors and ephrins in neural development.	EPHB2 EPHA8	1.74e-04	20	34	2	11256076
Pubmed	The Eph family receptors and ligands.	EPHB2 EPHA8	1.74e-04	20	34	2	9576626
Pubmed	The ephrins and Eph receptors in neural development.	EPHB2 EPHA8	1.74e-04	20	34	2	9530499
Pubmed	Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee.	EPHB2 EPHA8	1.93e-04	21	34	2	9267020
Pubmed	Developmental expression of Eph and ephrin family genes in mammalian small intestine.	EPHB2 EPHA8	1.93e-04	21	34	2	20112066
Pubmed	Eph receptors and ephrins demarcate cerebellar lobules before and during their formation.	EPHB2 EPHA8	1.93e-04	21	34	2	10495276
Pubmed	Roles of Eph receptors and ephrins in segmental patterning.	EPHB2 EPHA8	1.93e-04	21	34	2	11128993
Pubmed	Eph receptors and ephrins: regulators of guidance and assembly.	EPHB2 EPHA8	1.93e-04	21	34	2	10730216
Pubmed	Thalamic afferents influence cortical progenitors via ephrin A5-EphA4 interactions.	EPHB2 EPHA8	2.32e-04	23	34	2	25480914
Pubmed	Unravelling the transcriptional responses of TGF-β: Smad3 and EZH2 constitute a regulatory switch that controls neuroretinal epithelial cell fate specification.	EZH1 EZH2	2.32e-04	23	34	2	30779601
Pubmed	CATACOMB: An endogenous inducible gene that antagonizes H3K27 methylation activity of Polycomb repressive complex 2 via an H3K27M-like mechanism.	EZH1 EZH2	2.32e-04	23	34	2	31281901
Pubmed	Eph receptors and their ephrin ligands are expressed in developing mouse pancreas.	EPHB2 EPHA8	2.53e-04	24	34	2	16446123
Pubmed	Loss of Ezh2 promotes a midbrain-to-forebrain identity switch by direct gene derepression and Wnt-dependent regulation.	EZH1 EZH2	2.74e-04	25	34	2	26621269
Pubmed	Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin.	DIP2C DIP2B	3.45e-04	28	34	2	31600191
Pubmed	Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals.	SPTBN4 DIP2C CHUK	3.63e-04	142	34	3	19851296
Pubmed	Stage- and subunit-specific functions of polycomb repressive complex 2 in bladder urothelial formation and regeneration.	EZH1 EZH2	3.70e-04	29	34	2	28049658
Pubmed	Association of genetic variants with hemorrhagic stroke in Japanese individuals.	SPTBN4 DIP2C CHUK	3.71e-04	143	34	3	20198315
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	DIP2B RICTOR EZH2 INTS3 DHX38	3.99e-04	650	34	5	38777146
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	EZH1 EZH2 TRIO EPHA8	4.01e-04	358	34	4	32460013
Pubmed	Polycomb-Mediated Repression and Sonic Hedgehog Signaling Interact to Regulate Merkel Cell Specification during Skin Development.	EZH1 EZH2	4.81e-04	33	34	2	27414999
Pubmed	Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM.	EZH1 EZH2	4.81e-04	33	34	2	26864203
Pubmed	PRC1 sustains the integrity of neural fate in the absence of PRC2 function.	EZH1 EZH2	6.38e-04	38	34	2	34994686
Pubmed	New candidate genes identified for controlling mouse gonadal sex determination and the early stages of granulosa and Sertoli cell differentiation.	CSGALNACT1 MMD2	7.07e-04	40	34	2	19864314
Pubmed	Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature.	EPHB2 EPHA8	7.79e-04	42	34	2	11439183
Interaction	MORC3 interactions	SPTBN4 TRIM67 EZH2 KALRN	8.63e-06	80	33	4	int:MORC3
Interaction	RFX2 interactions	EYA2 TRIM67 FOXN4	1.27e-05	28	33	3	int:RFX2
Interaction	EIF2S3B interactions	TRIM67 EZH2 TRIO	1.42e-05	29	33	3	int:EIF2S3B
Interaction	NUDC interactions	ANKRD30B RICTOR GABARAPL2 TRIM67 EZH2 WDFY2	1.58e-05	337	33	6	int:NUDC
Interaction	KALRN interactions	EPHB2 TRIM67 TRIO KALRN	1.78e-05	96	33	4	int:KALRN
Interaction	ANK2 interactions	EPHB2 GABARAPL2 TRIM67 KALRN	1.93e-05	98	33	4	int:ANK2
Interaction	EDIL3 interactions	RICTOR TRIM67 EZH2	2.53e-05	35	33	3	int:EDIL3
Interaction	EPHB3 interactions	EPHB2 TRIM67 EPHA8	2.53e-05	35	33	3	int:EPHB3
Interaction	TASOR interactions	RICTOR TRIM67 EZH2 INTS3	3.04e-05	110	33	4	int:TASOR
Interaction	HACD3 interactions	EPHB2 GABARAPL2 TRIM67 EZH2 EPHA8	4.32e-05	242	33	5	int:HACD3
Interaction	CDC37 interactions	EPHB2 SPTBN4 GABARAPL2 TRIM67 TRIO CHUK EPHA8	6.88e-05	645	33	7	int:CDC37
Interaction	CYRIA interactions	RICTOR TRIM67	7.24e-05	8	33	2	int:CYRIA
Interaction	NUDT19 interactions	EPHB2 GABARAPL2 TRIM67 EPHA8	7.59e-05	139	33	4	int:NUDT19
Interaction	EPOP interactions	EZH1 EZH2 INTS3	8.37e-05	52	33	3	int:EPOP
Interaction	DIP2C interactions	DIP2C TRIM67	9.29e-05	9	33	2	int:DIP2C
Interaction	CTNND2 interactions	ZMYND19 TRIM67 KALRN	9.37e-05	54	33	3	int:CTNND2
Interaction	PDIA4 interactions	EPHB2 RICTOR TRIM67 EZH2 DHX38 EPHA8	9.88e-05	468	33	6	int:PDIA4
Interaction	TMSB10 interactions	RICTOR TRIM67 EZH2	1.05e-04	56	33	3	int:TMSB10
Interaction	INTS8 interactions	TRIM67 EZH2 INTS3	1.42e-04	62	33	3	int:INTS8
Interaction	HYOU1 interactions	EPHB2 RICTOR TRIM67 EZH2 EPHA8	1.54e-04	317	33	5	int:HYOU1
Interaction	ARFGAP2 interactions	RICTOR TRIM67 EZH2 EPHA8	1.58e-04	168	33	4	int:ARFGAP2
Interaction	ST13P5 interactions	RICTOR TRIM67	1.70e-04	12	33	2	int:ST13P5
Interaction	ZNG1E interactions	ZMYND19 TRIM67	1.70e-04	12	33	2	int:ZNG1E
Interaction	SEPTIN3 interactions	EPHB2 GABARAPL2 TRIM67	1.71e-04	66	33	3	int:SEPTIN3
Interaction	GIT1 interactions	EPHB2 RICTOR TRIM67 KALRN	1.73e-04	172	33	4	int:GIT1
Interaction	EFNA5 interactions	EPHB2 RICTOR EPHA8	1.86e-04	68	33	3	int:EFNA5
Interaction	AK3 interactions	GABARAPL2 TRIM67 EZH2	2.03e-04	70	33	3	int:AK3
Interaction	STK38 interactions	RICTOR TRIM67 EZH1 EZH2	2.15e-04	182	33	4	int:STK38
Interaction	SKIDA1 interactions	EZH1 EZH2	2.34e-04	14	33	2	int:SKIDA1
Interaction	TRIR interactions	RICTOR TRIM67 EZH2	2.40e-04	74	33	3	int:TRIR
Interaction	DIP2B interactions	EPHB2 DIP2B TRIM67	2.49e-04	75	33	3	int:DIP2B
Interaction	KRT6C interactions	RICTOR TRIM67 EZH2	2.59e-04	76	33	3	int:KRT6C
Interaction	NCOR1 interactions	RICTOR GABARAPL2 EYA2 EZH2 CHUK	2.89e-04	363	33	5	int:NCOR1
Interaction	RBBP4 interactions	RICTOR TRIM67 EZH1 EZH2 INTS3 CLASRP	2.96e-04	573	33	6	int:RBBP4
Interaction	RAB35 interactions	EPHB2 DIP2B RICTOR TRIM67 EZH2 TRIO	2.96e-04	573	33	6	int:RAB35
Interaction	TMSB4X interactions	RICTOR TRIM67 EZH2	3.02e-04	80	33	3	int:TMSB4X
Interaction	CLASRP interactions	TRIM67 EZH2 CLASRP	3.02e-04	80	33	3	int:CLASRP
Interaction	LRRC14 interactions	TRIM67 CHUK	3.08e-04	16	33	2	int:LRRC14
Interaction	WWC3 interactions	TRIM67 EZH2	3.08e-04	16	33	2	int:WWC3
Interaction	ZNF592 interactions	TRIM67 EZH2 INTS3	3.13e-04	81	33	3	int:ZNF592
Interaction	USP39 interactions	TRIM67 EZH2 DHX38 TPBG	3.13e-04	201	33	4	int:USP39
Interaction	MYO5A interactions	RICTOR TRIM67 EZH2 KALRN	3.31e-04	204	33	4	int:MYO5A
Interaction	TPX2 interactions	TRIM67 EZH1 EZH2 CHUK	3.31e-04	204	33	4	int:TPX2
Cytoband	Ensembl 112 genes in cytogenetic band chr2q24	PLA2R1 WDSUB1	3.79e-03	127	33	2	chr2q24
GeneFamily	Lysine methyltransferases\|Myb/SANT domain containing\|Polycomb repressive complex 2	EZH1 EZH2	2.97e-05	6	26	2	1347
GeneFamily	Fibronectin type III domain containing	EPHB2 TRIM67 KALRN EPHA8	7.59e-05	160	26	4	555
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG1 TRIO KALRN	1.14e-04	66	26	3	722
GeneFamily	Fibronectin type III domain containing\|Sterile alpha motif domain containing\|EPH receptors	EPHB2 EPHA8	1.79e-04	14	26	2	1095
GeneFamily	Sterile alpha motif domain containing	EPHB2 WDSUB1 EPHA8	2.67e-04	88	26	3	760
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	EZH1 EZH2	1.08e-03	34	26	2	487
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	EZH1 EZH2	2.62e-03	53	26	2	532
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	TRIO KALRN	2.23e-02	161	26	2	593
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	DIP2C DIP2B MED13L TRIO	1.35e-05	192	34	4	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	DIP2C DIP2B MED13L TRIO	1.55e-05	199	34	4	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	DIP2B RICTOR MED13L	1.48e-04	135	34	3	b128596653a5e3b64ed7f657bbfeda35438e2e48
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-like-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZMYND19 TRIM67 CSGALNACT1	1.71e-04	142	34	3	5690eee2ce1ecd02e34eac4193578bd13c4228b9
ToppCell	Endothelial-endothelial_cell_of_bronchial_vessel\|World / Lineage, Cell type, age group and donor	PLEKHG1 KALRN CSGALNACT1	2.67e-04	165	34	3	84e553d699ac56df89a77248f7308b9133e1b683
ToppCell	Endothelial-B-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	PLA2R1 KALRN CSGALNACT1	2.67e-04	165	34	3	10087d8bd2985906ef19547fe77eb178ae5e1638
ToppCell	Children_(3_yrs)-Immune-B_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PLEKHG1 TRIM67 CSGALNACT1	2.91e-04	170	34	3	e421f9eedf74baffda1d03707a710ece4b777f29
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 TRIO CSGALNACT1	3.01e-04	172	34	3	0c2d0bb767e5ce089b42ad49e8b303a103de2d5c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 TRIO CSGALNACT1	3.01e-04	172	34	3	eeed177a03c116e9815a8e086d24efc9643b16a4
ToppCell	Adult-Endothelial-endothelial_cell_of_bronchial_vessel\|Adult / Lineage, Cell type, age group and donor	PLEKHG1 KALRN CSGALNACT1	3.01e-04	172	34	3	ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122\|Adult / Lineage, Cell type, age group and donor	PLEKHG1 KALRN CSGALNACT1	3.06e-04	173	34	3	dba09ba9748871e38a16449d500ae4d7b405c42f
ToppCell	Control-Neuronal_cells\|Control / group, cell type (main and fine annotations)	PLEKHG1 KALRN CSGALNACT1	3.22e-04	176	34	3	c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCell	Control-Neuronal_cells-Neuronal_cells\|Control / group, cell type (main and fine annotations)	PLEKHG1 KALRN CSGALNACT1	3.22e-04	176	34	3	98c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	DIP2C RICTOR EZH1	3.27e-04	177	34	3	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175\|Adult / Lineage, Cell type, age group and donor	PLEKHG1 KALRN CSGALNACT1	3.27e-04	177	34	3	c9f269765c7d5d29caab75910e51645606ed562e
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231\|Adult / Lineage, Cell type, age group and donor	PLEKHG1 KALRN CSGALNACT1	3.33e-04	178	34	3	c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815
ToppCell	droplet-Liver-nan-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLEKHG1 PLA2R1 KALRN	3.50e-04	181	34	3	fcc94f04dae98b817ec06b282d2e887804d37ae5
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DIP2C TRIO KALRN	3.55e-04	182	34	3	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Basal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB2 EYA2 TPBG	3.61e-04	183	34	3	ecac1cfaff7553a60305b34d6cede6973ffb5430
ToppCell	facs-Lung-EPCAM-3m-Epithelial-respiratory_basal_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB2 EYA2 TPBG	3.61e-04	183	34	3	f6ebfd7f61e912f92bd07313cc213a171747ac03
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG1 TRIO CSGALNACT1	3.67e-04	184	34	3	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DIP2C PPP2R3A CSGALNACT1	3.79e-04	186	34	3	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DIP2C PPP2R3A CSGALNACT1	3.85e-04	187	34	3	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	IPF-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	PLEKHG1 DIP2B TRIO	3.85e-04	187	34	3	af1327559f7e01bec070881cae52834917c3da65
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175\|Adult / Lineage, Cell type, age group and donor	PLEKHG1 KALRN CSGALNACT1	3.85e-04	187	34	3	1e52d3d9d664c813d859b5b75e4c07b218818f95
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DIP2C PPP2R3A CSGALNACT1	3.91e-04	188	34	3	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRIM67 TPBG EPHA8	3.91e-04	188	34	3	1efbc99bcd6542e5d9fa91edb7c4295167914786
ToppCell	COPD-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	PLEKHG1 MED13L KALRN	3.91e-04	188	34	3	1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PLEKHG1 KALRN CSGALNACT1	3.91e-04	188	34	3	c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PLEKHG1 KALRN CSGALNACT1	3.91e-04	188	34	3	aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCell	droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DIP2C PLEKHG1 KLHDC4	3.97e-04	189	34	3	98f517af255ef234eefc3ed7e6c1d63331ab8af0
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 TRIO CSGALNACT1	3.97e-04	189	34	3	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN4 TRIM67 EPHA8	3.97e-04	189	34	3	f57200c93d39c9bce1adba0a6a1c178c028dd86b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 TRIO CSGALNACT1	3.97e-04	189	34	3	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DIP2C PLEKHG1 KLHDC4	3.97e-04	189	34	3	f7e9b6e6a4de297b660a5b6c9a62f860c147185e
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel\|Adult / Lineage, Cell type, age group and donor	PLEKHG1 KALRN CSGALNACT1	4.03e-04	190	34	3	91bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PLEKHG1 KALRN CSGALNACT1	4.03e-04	190	34	3	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLEKHG1 EZH2 TRIO	4.03e-04	190	34	3	0db545a4cba7534bad2693e0d565cde7dbc7a586
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PLA2R1 EYA2 KALRN	4.09e-04	191	34	3	fa380a8752de158974b2ae5e741573439719cc0d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 PPP2R3A TRIO	4.09e-04	191	34	3	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 PPP2R3A TRIO	4.09e-04	191	34	3	9032aa974aa1b7b1095b8d1b58dcb087358a5001
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 PPP2R3A TRIO	4.09e-04	191	34	3	5717809a1476c20f65bce722c5a57cff92ee0d7a
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLEKHG1 PLA2R1 CSGALNACT1	4.09e-04	191	34	3	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_3\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	EPHB2 TRIO TPBG	4.15e-04	192	34	3	d88753b200d9c8da6716222d697ddf0a1548d6c8
ToppCell	3'-Distal_airway-Endothelial-Lymphatic_EC\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLEKHG1 AGPAT5 KALRN	4.15e-04	192	34	3	2ec132a1740e865e7cc0f82ffd4772d43f7ac086
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	EYA2 CSGALNACT1 TPBG	4.15e-04	192	34	3	3a6f2c255da46a0b0f5b657b0f56f3d7798ae85a
ToppCell	3'-Distal_airway-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLEKHG1 AGPAT5 KALRN	4.15e-04	192	34	3	3792c53b5d4b759573e1c7bb89ef9b654c9cbfcd
ToppCell	3'-Distal_airway-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLEKHG1 AGPAT5 KALRN	4.15e-04	192	34	3	64022a47dccd7966777f6741d1c68e298f37ca9d
ToppCell	3'-Distal_airway-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLEKHG1 AGPAT5 KALRN	4.15e-04	192	34	3	f67a88bd039944d3d7a5a4a9f2e053985075155c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG1 KALRN CSGALNACT1	4.15e-04	192	34	3	28eb3a5728e8901bcb5ba12f6b009f41b065fa37
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 DIP2C CSGALNACT1	4.22e-04	193	34	3	ca7c0a4ceb05bced90f6cdc53d278e547fb241e9
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLEKHG1 AGPAT5 EZH2	4.28e-04	194	34	3	5cd72330c9d9bb21b6c9d5d35085eade101486d1
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	AGPAT5 EZH2 FOXN4	4.28e-04	194	34	3	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG1 TRIO CSGALNACT1	4.35e-04	195	34	3	938b31dbf1674ee6fd0123bc88391ddcaf151217
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG1 KALRN CSGALNACT1	4.35e-04	195	34	3	6bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG1 TRIO CSGALNACT1	4.35e-04	195	34	3	d39e9e6544f49e677ebe528c6fe60b99a3630e30
ToppCell	367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	DIP2C EYA2 CSGALNACT1	4.35e-04	195	34	3	4008fa86b5166087a4b20f89ae07e1dfc87c855d
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHG1 AGPAT5 FOXN4	4.41e-04	196	34	3	de43dd0697e1daf4d50800957cf0b27b54a7a333
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	DIP2C PLA2R1 KALRN	4.48e-04	197	34	3	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHG1 KALRN CSGALNACT1	4.54e-04	198	34	3	9ab0db78394e730f6866b2db80047149024ad5f6
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	DIP2C MED13L TRIO	4.54e-04	198	34	3	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG1 KALRN CSGALNACT1	4.54e-04	198	34	3	b027a141ab531d0f5d6a26811a53427e7b0771dd
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHG1 KALRN CSGALNACT1	4.54e-04	198	34	3	b3a020522e064bb61949d38e442f24026e339364
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHG1 KALRN CSGALNACT1	4.54e-04	198	34	3	fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG1 KALRN CSGALNACT1	4.54e-04	198	34	3	8e45551224fbb30c0658ad47dd98335ecf165437
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHG1 KALRN CSGALNACT1	4.54e-04	198	34	3	e47d0e2c6353315c85d7007742bb16b0f05795ed
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG1 KALRN CSGALNACT1	4.54e-04	198	34	3	953630dbe3154b1b102b87de0feca2cbf124eabe
ToppCell	Parenchymal-NucSeq-Endothelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHG1 KALRN CSGALNACT1	4.61e-04	199	34	3	a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e
ToppCell	Hematolymphoid-Microglia\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	MED13L CSGALNACT1 WDFY2	4.68e-04	200	34	3	21bcca3b670fe9bac034aef2275d3de4a9a73e2b
ToppCell	Hematolymphoid-Microglia-TYROBP----L1-3\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	MED13L CSGALNACT1 WDFY2	4.68e-04	200	34	3	a20dce14f94777687aad57d6fbe3258ad376f63f
ToppCell	Hematolymphoid-Microglia-TYROBP--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	MED13L CSGALNACT1 WDFY2	4.68e-04	200	34	3	dc344b3ec51d506952e38f0b3a7795d65f9dd4eb
ToppCell	Hematolymphoid-Microglia-TYROBP---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	MED13L CSGALNACT1 WDFY2	4.68e-04	200	34	3	a8646d0fca99f10827c2d2a12e584660ef7155f1
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-Macroglial-Astrocyte\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	PLEKHG1 EYA2 CSGALNACT1	4.68e-04	200	34	3	4fe3b2d80c567c18621bff3341f9a73578c81621
ToppCell	Hematolymphoid-Microglia-TYROBP-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	MED13L CSGALNACT1 WDFY2	4.68e-04	200	34	3	3bba5219453322198e8fdb0921d5f8c403598751
ToppCell	Hematolymphoid-Microglia-TYROBP\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	MED13L CSGALNACT1 WDFY2	4.68e-04	200	34	3	33036d21c1c82109284473a515c4f890b33fdd5c
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLA2R1 PPP2R3A EYA2	4.68e-04	200	34	3	7c2d499af60654b7b28f172ac2c914ad49fb74b4
Drug	7-heptacosene	EZH1 EZH2	5.74e-06	3	32	2	CID006430696
Disease	interferon gamma measurement	EPHB2 TPBG EPHA8	2.56e-05	51	33	3	EFO_0008165
Disease	colon cancer (is_marker_for)	RICTOR EZH2 CHUK	3.97e-05	59	33	3	DOID:219 (is_marker_for)
Disease	complement C1q subcomponent subunit C measurement	EPHB2 EPHA8	5.43e-05	10	33	2	EFO_0801492
Disease	rostral middle frontal gyrus volume measurement	ZMYND19 PLA2R1	1.09e-04	14	33	2	EFO_0010328
Disease	tumor necrosis factor beta measurement	EPHB2 EPHA8	1.26e-04	15	33	2	EFO_0008308
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	DIP2B TRIO	1.63e-04	17	33	2	DOID:0060307 (is_implicated_in)
Disease	macrophage colony stimulating factor measurement	EPHB2 EPHA8	7.88e-04	37	33	2	EFO_0008217
Disease	Metastatic melanoma	TRIO EPHA8	1.67e-03	54	33	2	C0278883
Disease	Ischemic stroke, fibrinogen measurement	DIP2B PPP2R3A	1.74e-03	55	33	2	EFO_0004623, HP_0002140
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	PPP2R3A CSGALNACT1 DHX38	1.77e-03	215	33	3	EFO_0008317, EFO_0008591
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	PPP2R3A CSGALNACT1 DHX38	1.89e-03	220	33	3	EFO_0004529, EFO_0008317
Disease	fibrinogen measurement, factor VII measurement	DIP2B PPP2R3A	1.93e-03	58	33	2	EFO_0004619, EFO_0004623
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	PPP2R3A CSGALNACT1 DHX38	1.99e-03	224	33	3	EFO_0004574, EFO_0008317
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	PPP2R3A CSGALNACT1 DHX38	2.12e-03	229	33	3	EFO_0004639, EFO_0008317
Disease	retinal vasculature measurement	PLEKHG1 PPP2R3A MED13L TRIO	2.55e-03	517	33	4	EFO_0010554
Disease	nephrotic syndrome	ZNF438 KALRN	2.87e-03	71	33	2	EFO_0004255
Disease	very low density lipoprotein cholesterol measurement	PPP2R3A CSGALNACT1 DHX38	3.03e-03	260	33	3	EFO_0008317
Disease	lung cancer (is_implicated_in)	RICTOR EZH2	3.12e-03	74	33	2	DOID:1324 (is_implicated_in)
Disease	esophagus squamous cell carcinoma (is_marker_for)	RICTOR EZH2	3.12e-03	74	33	2	DOID:3748 (is_marker_for)
Disease	Cleft Palate	MED13L CHUK	3.72e-03	81	33	2	C0008925
Disease	otosclerosis	ZNF438 EYA2	3.72e-03	81	33	2	EFO_0004213
Disease	sleep duration, low density lipoprotein cholesterol measurement	DHX38 CLASRP	4.67e-03	91	33	2	EFO_0004611, EFO_0005271
Disease	Neurodevelopmental Disorders	MED13L TRIO	4.87e-03	93	33	2	C1535926
Disease	malaria	DIP2C PLEKHG1	5.83e-03	102	33	2	EFO_0001068
Disease	DNA methylation	MMD2 TRIO MMD2 TPBG	5.94e-03	656	33	4	GO_0006306

Protein segments in the cluster

Peptide	Gene	Start	Entry
MKKRTALHWACVNGH	ANKRD30B	71	Q9BXX2
GLFHLWHEKRCMDEL	CSGALNACT1	471	Q8TDX6
ILRHWCMKHDELLAE	INTS3	876	Q68E01
WKKSHLRMVEHCLHM	MMD2	91	Q8IY49
KLHNHMVHRVWKECI	MED13L	371	Q71F56
ERWCHEIQIMKKLNH	CHUK	56	O15111
HQLMLDCWQKDRNHR	EPHB2	856	P29323
HRLWAAHCRKIQLKK	EZH2	496	Q15910
HQMWHVRKLKLDQCF	KALRN	296	O60229
KCRDLHWAMMAHRDQ	DIP2B	611	Q9P265
MWRKLLNNHHDDASK	PPP2R3A	786	Q06190
KCHNWDAVRHSRKHL	RICTOR	986	Q6R327
ALHQLMLDCWHKDRA	EPHA8	866	P29322
VKSRDMHWALVAHRD	DIP2C	591	Q9Y2E4
SDLHCLDLHRMEAWK	KLHDC4	461	Q8TBB5
MKWMFKEDHSLEHRC	GABARAPL2	1	P60520
KKHNMPFWRISCHAD	EYA2	511	O00167
EMHKWKRKDLAAIHR	FOXN4	281	Q96NZ1
HKKKHMRWRSLCCQG	NANOGNB	166	Q7Z5D8
LGRWEVKHCRHFKAM	PLA2R1	626	Q13018
MWHEARKHERKLRGM	CLASRP	1	Q8N2M8
REHKLKMVWDQINHC	TRIM67	416	Q6ZTA4
QQKDWPAHKKHCRER	ZMYND19	201	Q96E35
MWDSKKIGLRQHHCR	WDFY2	301	Q96P53
QKKKRKHRLWAAHCR	EZH1	491	Q92800
KHRLWAAHCRKIQLK	EZH1	496	Q92800
NHKLHKRWLRHQAFM	SPTBN4	1336	Q9H254
IWCNDHFIHAKAMRK	DHX38	1026	Q92620
IKKWMHNIRDACRDH	TPBG	381	Q13641
VAWHINDMKRKHEHA	PLEKHG1	286	Q9ULL1
WDDKMRCLHSEKAHD	WDSUB1	166	Q8N9V3
HMRRWLHERFEIKDK	AGPAT5	276	Q9NUQ2
CAEMLGRKEDLLHHW	ZNF438	781	Q7Z4V0
HQMWHVRKLKLDQCF	TRIO	326	O75962